Loan & DebtJun 24, 2026, 07:01 AM
CalciMedica Amends Loan, Extends Maturity to 2029; Warrants Adjusted
AI Summary
CalciMedica, Inc. amended its loan and security agreement with Avenue Venture Opportunities Fund II, L.P., extending the interest-only period to September 30, 2027, and the maturity date to September 1, 2029, for its $10 million loan. The company agreed to increase the final payment fee by $200,000. Additionally, the lender's conversion option was expanded to $3 million, and an existing warrant's exercise price was reduced from $2.32 to $1.00, while a new warrant for 1 million shares at $1.00 was issued.
Key Highlights
- Loan interest-only period extended to September 30, 2027.
- Loan maturity date extended to September 1, 2029.
- Final payment fee increased by $200,000.
- Lender's conversion option increased to $3,000,000.
- Existing warrant exercise price reduced from $2.32 to $1.00.
- New warrant issued for 1,000,000 shares at $1.00 exercise price.
Price Impact
More from CALC